FDA Cracks Down on Improper Marketing of SARS-CoV-2 Antibody Tests
...
Already a member? Log in here
G2 Insider-dtet
Supreme Court May Take on Its First Health Care Data Breach Case
From - Diagnostic Testing & Emerging Technologies
In a case to watch, CareFirst BlueCross BlueShield will ask the U.S. Supreme Court to consider its first health care data breach case. CareFirst is arguing that the…
Don’t Crash & Burn: Why Cutting Your Quality Department’s Budget is not a Good Idea
By Jennifer Dawson, MHA, DLM (ASCP) bio
Do you think that you can improve your organization's bottom line by reducing the budget to your quality program and cutting its staff…
Corporate Venture Capital Ups Investments in Health Deals
From - Diagnostic Testing & Emerging Technologies
Health care corporate venture capital (CVC) is increasing across all sectors of the industry in terms of number of deals, dollars invested, and number of…
U.S. Colorectal Cancer Screening Capacity Exists, Although Actual Rates Remain Low
From - Diagnostic Testing & Emerging Technologies
The United States has the screening capacity to meet colorectal screening goals, but this capacity has so far not translated into increased screening rates, according to a…
C. Diff Screening at Admission Can Cut Hospital- Acquired Infection
...
Already a member? Log in here
CDC Expands MicrobeNet Pathogen Library With Help From Industry
From - Diagnostic Testing & Emerging Technologies
The U.S. Centers for Disease Control and Prevention (CDC) recently announced another new partnership with industry to expand the utility of…
Genetic Test Registry Finds Growth of Oncology, NGS-Based Tests
From - Diagnostic Testing & Emerging Technologies
The number of cancer gene tests has grown tremendously in the past two years, particularly in the field of oncology where the number of tests grew by…
Biden Launches Genomic Data Commons to Aid Sharing in Oncology
From - Diagnostic Testing & Emerging Technologies
Genomic Data Commons (GDC) launched this week as a core component of the National Cancer Moonshot and the President's Precision Medicine Initiative to promote data sharing between cancer researchers and accelerate the pace of…
Global Lab Network Expands Measles, Rubella Surveillance Capacity
From - Diagnostic Testing & Emerging Technologies
From 2010 to 2015 the Global Measles and Rubella Laboratory Network (GMRLN) substantially increased its capacity to provide real-time disease surveillance and…
Low Histopathologic Agreement for DCIS, Atypia Breast Cancer
...
Already a member? Log in here
Adherence Poor for Lynch Syndrome Testing
...
Already a member? Log in here